Current Status of Clinical Trials of Therapeutic Modalities for Malignant Melanoma in Australia
- 28 July 1989
- journal article
- review article
- Published by Wiley in Pigment Cell Research
- Vol. 2 (4) , 370-371
- https://doi.org/10.1111/j.1600-0749.1989.tb00223.x
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Phase-II Study of Recombinant α2-Interferon in Advanced Malignant MelanomaJournal of Interferon Research, 1986
- Chemotherapy in metastatic melanoma: Phase II studies of amsacrine, mitoxantrone and bisantreneEuropean Journal of Cancer and Clinical Oncology, 1986
- Effects of recombinant leukocyte interferon (rIFN-α A) on tumour growth and immune responses in patients with metastatic melanomaBritish Journal of Cancer, 1985
- On the receiving end—II. Linear analogue self-assessment (LASA) in evaluation of aspects of the quality of life of cancer patients receiving therapyEuropean Journal of Cancer and Clinical Oncology, 1983
- On the receiving end—patient perception of the side-effects of cancer chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1983
- Design of forms for clinical trials (3).BMJ, 1979